Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117746 | SCV000151999 | uncertain significance | not provided | 2013-08-23 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000665740 | SCV000789908 | uncertain significance | Nemaline myopathy 2 | 2017-03-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000665740 | SCV001416668 | benign | Nemaline myopathy 2 | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000117746 | SCV001774238 | uncertain significance | not provided | 2022-05-16 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Revvity Omics, |
RCV000117746 | SCV003810170 | uncertain significance | not provided | 2023-09-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000117746 | SCV005187934 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000665740 | SCV002084035 | uncertain significance | Nemaline myopathy 2 | 2020-01-17 | no assertion criteria provided | clinical testing |